Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sinopharm Sanyi Pharmaceutical (Wuhu) Co., Ltd., formerly known as Wuhu Sanyi Xincheng Pharmaceutical, is a specialized Chinese pharmaceutical manufacturer focusing on topical and ophthalmic medications. As a subsidiary of the state-owned Sinopharm Group, specifically under Sinopharm Modern Pharmaceutical, the company operates as a key production hub for external-use drugs including ointments, gels, eye drops, and liniments. Its facility in Wuhu, Anhui, features 15 GMP-certified production lines with an annual capacity exceeding 100 million units. The company's commercial portfolio includes prominent products such as erythromycin ointment, clobetasol propionate liniment, and various ophthalmic formulations for treating ocular infections and inflammations. It serves as a high-tech industrialization platform for Sinopharm's topical drug segment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sanyi Xincheng Pharmaceutical.